As of 2026-10-03, the EV/EBITDA ratio of bluebird bio Inc (BLUE) is -1.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLUE's latest enterprise value is 129.30 mil USD. BLUE's TTM EBITDA according to its financial statements is -116.20 mil USD. Dividing these 2 quantities gives us the above BLUE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.7x - 17.3x | 16.2x |
| Forward P/E multiples | 18.5x - 22.5x | 20.4x |
| Fair Price | (227.83) - (213.82) | (225.16) |
| Upside | -4684.1% - -4402.3% | -4630.3% |
| Date | EV/EBITDA |